EFALIZUMABUM Chemische Eigenschaften,Einsatz,Produktion Methoden

Originator

XOMA (US)

Verwenden

Treatment of transplant rejections; antipsoriatic (immunomodulator monoclonal antibody which decreases the activation, migration, and adhesion of T-cells). hu1124; anti-CD11a.

Trademarks

Raptiva

EFALIZUMABUM Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

EFALIZUMABUM Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific		tp@aladdinsci.com	United States	57505	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10308	58
Shanghai YuanYe Biotechnology Co., Ltd.	021-61312847; 18021002903	3008007409@qq.com	China	71826	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	7972	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24982	58
Biolab Reagents	18108604356	info@biolabreagent.com	China	9868	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	6216	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11973	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	400-6206333 13167063860	anhua.mao@aladdin-e.com	China	48457	58

---

• EFALIZUMABUM
• Research Grade Efalizumab(DHD41001)
• Efalizumab (anti-ITGAL)
• Hu1124|||HU 1124
• Research Grade Efalizumab
• 214745-43-4